Home LiteratureArticle Details
PMID: 25177210 Published · epublish English Journal Article

Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma.

BMC clinical pathology ·Vol. 14 ·2014-00-00 ·Pages 38

Wirsing AM, Rikardsen OG, Steigen SE, Uhlin-Hansen L, Hadler-Olsen E

Abstract

Oral squamous cell carcinomas are often heavily infiltrated by immune cells. The organization of B-cells, follicular dendritic cells, T-cells and high-endothelial venules into structures termed tertiary lymphoid structures have been detected in various types of cancer, where their presence is found to predict favourable outcome. The purpose of the present study was to evaluate the incidence of tertiary lymphoid structures in oral squamous cell carcinomas, and if present, analyse whether they were associated with clinical outcome. Tumour samples from 80 patients with oral squamous cell carcinoma were immunohistochemically stained for B-cells, follicular dendritic cells, T-cells, germinal centre B-cells and high-endothelial venules. Some samples were sectioned at multiple levels to assess whether the presence of tertiary lymphoid structures varied within the tumour. Tumour-associated tertiary lymphoid structures were detected in 21 % of the tumours and were associated with lower disease-specific death. The presence of tertiary lymphoid structures varied within different levels of a tissue block. Tertiary lymphoid structure formation was found to be a positive prognostic factor for patients with oral squamous cell carcinoma. Increased knowledge about tertiary lymphoid structure formation in oral squamous cell carcinoma might help to develop and guide immune-modulatory cancer treatments.

Keywords
B-cell Follicular dendritic cell Germinal centre High-endothelial venule Oral squamous cell carcinoma Prognostic factor Tertiary lymphoid structure
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wirsing Anna M
Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø 9037, Norway.
Rikardsen Oddveig G
Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø 9037, Norway ; Department of Otorhinolaryngology, University Hospital of North Norway, Tromsø 9038, Norway.
Steigen Sonja E
Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø 9037, Norway ; Diagnostic Clinic - Clinical Pathology, University Hospital of North Norway, Tromsø 9038, Norway.
Uhlin-Hansen Lars
Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø 9037, Norway ; Diagnostic Clinic - Clinical Pathology, University Hospital of North Norway, Tromsø 9038, Norway.
Hadler-Olsen Elin
Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø 9037, Norway.
References (31)
31 references, click to expand
  1. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
    J Clin Oncol. 2008 Sep 20;26(27):4410-7 PMID: 18802153
  2. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
    Cancer Res. 2014 Feb 1;74(3):705-15 PMID: 24366885
  3. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.
    Clin Cancer Res. 2013 Aug 1;19(15):4079-91 PMID: 23785047
  4. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.
    Clin Cancer Res. 2014 Apr 15;20(8):2147-58 PMID: 24523438
  5. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas.
    Cancer Res. 2003 Jun 15;63(12):3275-80 PMID: 12810659
  6. Antitumor immunity and cancer stem cells.
    Ann N Y Acad Sci. 2009 Sep;1176:154-69 PMID: 19796244
  7. The immune microenvironment of human tumors: general significance and clinical impact.
    Cancer Microenviron. 2013 Aug;6(2):117-22 PMID: 23108700
  8. REporting recommendations for tumour MARKer prognostic studies (REMARK).
    Br J Cancer. 2005 Aug 22;93(4):387-91 PMID: 16106245
  9. Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma.
    Oral Dis. 2006 Sep;12(5):443-54 PMID: 16910914
  10. Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: Parallels with lymph node stroma.
    Front Immunol. 2012 Nov 30;3:350 PMID: 23230435
  11. The immune contexture in human tumours: impact on clinical outcome.
    Nat Rev Cancer. 2012 Mar 15;12(4):298-306 PMID: 22419253
  12. The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.
    Immunol Res. 2013 Dec;57(1-3):52-69 PMID: 24218361
  13. Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer.
    Oncoimmunology. 2012 Aug 1;1(5):789-790 PMID: 22934284
  14. Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation.
    Cancer Res. 2004 Jul 1;64(13):4405-10 PMID: 15231647
  15. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
    Am J Respir Crit Care Med. 2014 Apr 1;189(7):832-44 PMID: 24484236
  16. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2006 Mar;42(3):229-39 PMID: 16150633
  17. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium.
    J Immunol. 2002 May 15;168(10):5333-41 PMID: 11994492
  18. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report.
    Head Neck. 2002 Feb;24(2):165-80 PMID: 11891947
  19. Tertiary intratumor lymphoid tissue in colo-rectal cancer.
    Cancers (Basel). 2011 Dec 28;4(1):1-10 PMID: 24213222
  20. Oral squamous cell carcinoma: review of prognostic and predictive factors.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):67-76 PMID: 16831675
  21. Organogenesis of lymphoid tissues.
    Nat Rev Immunol. 2003 Apr;3(4):292-303 PMID: 12669020
  22. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis.
    Head Neck. 2009 Dec;31(12):1544-56 PMID: 19424974
  23. CD20+ B cells: the other tumor-infiltrating lymphocytes.
    J Immunol. 2010 Nov 1;185(9):4977-82 PMID: 20962266
  24. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.
    Virchows Arch. 2010 Dec;457(6):677-92 PMID: 20890764
  25. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.
    Clin Cancer Res. 2009 Oct 15;15(20):6412-20 PMID: 19825961
  26. Lymphoid neogenesis in chronic inflammatory diseases.
    Nat Rev Immunol. 2006 Mar;6(3):205-17 PMID: 16498451
  27. Lymphoid organ development: from ontogeny to neogenesis.
    Nat Immunol. 2006 Apr;7(4):344-53 PMID: 16550197
  28. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.
    J Clin Oncol. 2013 Dec 20;31(36):4550-9 PMID: 24248688
  29. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.
    Am J Pathol. 2011 Jul;179(1):37-45 PMID: 21703392
  30. Characteristics of tertiary lymphoid structures in primary cancers.
    Oncoimmunology. 2013 Dec 1;2(12):e26836 PMID: 24498556
  31. Tertiary lymphoid organs in infection and autoimmunity.
    Trends Immunol. 2012 Jun;33(6):297-305 PMID: 22622061
Article Info
Journal
BMC clinical pathology
Abbr.
BMC Clin Pathol
ISSN
1472-6890
Published
2014-00-00
Epub
2014-00-23
Pages
38
Language
English
Region
England
NLM ID
101088665
PMCID
PMC4148494
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com